Mabwell Bioscience-B（02493）
Innovative biotech focused on oncology & age-related diseases; core Nectin-4 ADC 9MW2821 in pivotal Phase III; 4 biosimilars launched
Progress
Subscription Opens
Apr 20, 2026, 07:00 AM UTC+0
Subscription Closes
Apr 22, 2026, 04:00 AM UTC+0
Allotment Results
Apr 23, 2026 UTC+0
Listed
Apr 27, 2026 UTC+0
Details
Offer Price
27.64～30.71HKD
Shares per Lot
--
Minimum Subscription Amount
--HKD
Market Cap
--
Shares Issued
--
Clawback Mechanism
--
Public Offer Ratio
--
Industry Sector
Healthcare
Greenshoe
--
Sponsor
--
Prospectus
Prospectus.pdfUse of Funds
Name
Subscribed Shares/Proportion
Unlock Date
No data
Underwriters 0 in total
No data